Description
Indian subsidiary of the Swiss Extrovis group, incorporated in Hyderabad in 2017. It develops active ingredients and finished dosage forms aimed at generics and reformulated products, with a declared team of some sixty scientists at Kukatpally. The group also holds a Hungarian entity acting as its regulatory bridge into the European Union market.